3,000
Participants
Start Date
March 5, 2021
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2030
Cognitive test scores, clinical diagnosis and blood biomarkers
"Clinical diagnosis of Alzheimer's disease, mild cognitive impairment or normal ageing.~Cognitive test score on CANTAB Blood biomarker (p-tau 181) level"
RECRUITING
University of Tasmania, Hobart
National Health and Medical Research Council, Australia
OTHER
University of Sydney
OTHER
University of Leeds
OTHER
University of Tasmania
OTHER